Anabolic steroids have therapeutic use and may be prescribed to treat problems such as muscle degeneration associated with disease, male hormone issues, and late onset of puberty. However, some individuals use anabolic steroids illegally to improve athletic performance and build muscle mass. Abuse of anabolic steroid hormones disrupts the normal production of hormones in the body. There are several negative health consequences associated with anabolic steroid abuse. Some of these include infertility, hair loss, breast development in males, heart attacks, and liver tumors . Anabolic steroids also effect the brain causing mood swings and depression.
Human Growth Hormone is an injectable hormone that can be administered subcutaneously or intramuscularly. When injected subcutaneously, HGH carries a bioavailability of approximately seventy-five percent. When injected intramuscularly, HGH carries a bioavailability of approximately sixty-three percent. The mode of administration will also affect the half-life of the Somatropin hormone. When injected subcutaneously, it will carry a half-life of approximately hours. When injected intramuscularly, it will carry a half-life of approximately hours. While this is a rather short half-life regardless of the mode of administration, keep in mind the total effects far outlast these numbers due to the pronounced and significant increases in IGF-1 production that stretch far past the twenty-four hour mark.
Because non-genomic pathways include any mechanism that is not a genomic effect, there are various non-genomic pathways. However, all of these pathways are mediated by some type of steroid hormone receptor found at the plasma membrane.  Ion channels, transporters, G-protein coupled receptors (GPCR), and membrane fluidity have all been shown to be affected by steroid hormones.  Of these, GPCR linked proteins are the most more information on these proteins and pathways, visit the steroid hormone receptor page.